Related references
Note: Only part of the references are listed.Neurological and psychiatric management using COMT inhibitors: A review
Md Jawaid Akhtar et al.
BIOORGANIC CHEMISTRY (2020)
Clinically Precedented Protein Kinases: Rationale for Their Use in Neurodegenerative Disease
Caroline L. Benn et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Target 2035: probing the human proteome
Adrian J. Carter et al.
DRUG DISCOVERY TODAY (2019)
PRMTs and Arginine Methylation: Cancer's Best-Kept Secret?
James Jarrold et al.
TRENDS IN MOLECULAR MEDICINE (2019)
Methyltransferase Inhibitors: Competing with, or Exploiting the Bound Cofactor
Renato Ferreira de Freitas et al.
MOLECULES (2019)
A chemical biology toolbox to study protein methyltransferases and epigenetic signaling
Sebastian Scheer et al.
NATURE COMMUNICATIONS (2019)
Towards the structural characterization of the human methyltransferome
Michael K. Fenwick et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2018)
Kinetic Mechanism of Nicotinamide N-Methyltransferase
Heather S. Loring et al.
BIOCHEMISTRY (2018)
Rules of Engagement: GPCRs and G Proteins
Alisa Glukhova et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2018)
Target class drug discovery
Kimberly D. Barnash et al.
NATURE CHEMICAL BIOLOGY (2017)
Dysregulation of protein methyltransferases in human cancer: An emerging target class for anticancer therapy
Ryuji Hamamoto et al.
CANCER SCIENCE (2016)
Chemical Proteomic Profiling of Human Methyltransferases
Benjamin D. Horning et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Convergent Mechanistic Features between the Structurally Diverse N- and O-Methyltransferases: Glycine N-Methyltransferase and Catechol O-Methyltransferase
Jianyu Zhang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Methyltransferase-Glo: a universal, bioluminescent and homogenous assay for monitoring all classes of methyltransferases
Kevin Hsiao et al.
EPIGENOMICS (2016)
DNA Methylation, Its Mediators and Genome Integrity
Huan Meng et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2015)
Structure-based drug design of catechol-O-methyltransferase inhibitors for CNS disorders
Zhiguo Ma et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Structure-Based and Fragment-Based GPCR Drug Discovery
Stephen P. Andrews et al.
CHEMMEDCHEM (2014)
The multi-functional roles of GNMT in toxicology and cancer
Chia-Hung Yen et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Characterization of Non-Nitrocatechol Pan and Isoform Specific Catechol-O-methyltransferase Inhibitors and Substrates
Ronald G. Robinson et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Inhibitors of Catechol-O-Methyltransferase
James C. Barrow
CNS & Neurological Disorders-Drug Targets (2012)
Architectures, mechanisms and molecular evolution of natural product methyltransferases
David K. Liscombe et al.
NATURAL PRODUCT REPORTS (2012)
Trends in Kinase Selectivity Insights for Target Class-Focused Library Screening
Shana L. Posy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Comprehensive Structural and Substrate Specificity Classification of the Saccharomyces cerevisiae Methyltransferome
Tomasz Wlodarski et al.
PLOS ONE (2011)
G-protein-coupled receptor-focused drug discovery using a target class platform approach
Ralf Heilker et al.
DRUG DISCOVERY TODAY (2009)
Protein methyltransferases as a target class for drug discovery
Robert A. Copeland et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
High-throughput kinase profiling as a platform for drug discovery
David M. Goldstein et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Folate status modulates the induction of hepatic glycine N-methyltransferase and homocysteine metabolism in diabetic rats
Kristin M. Nieman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Natural history of S-adenosylmethionine-binding proteins -: art. no. 19
PZ Kozbial et al.
BMC STRUCTURAL BIOLOGY (2005)
Two polymorphic forms of human histamine methyltransferase: Structural, thermal and kinetic comparisons
JR Horton et al.
STRUCTURE (2001)
Share Paper
